Radium-223 use and survival by line of treatment in metastatic castration-resistant prostate cancer: a nationwide population-based register study
20251 citationsJournal Articlediamond Open Access
Field-Weighted Citation Impact: 1.48
Radium-223 use and survival by line of treatment in metastatic castration-resistant prostate cancer: a nationwide population-based register study | Researchclopedia